Investing in Alcon (ALC)

Valuation methodValue, $Upside, %
Artificial intelligence (AI)5.96-93
Intrinsic value (DCF)4.19-95
Graham-Dodd Method6.49-92
Graham Formula14.90-82

Company description

ALC (Alcon Inc.) is a multi-national pharmaceutical and medical device company with a long-standing history in the healthcare industry. The company operates in over 70 countries and has a diverse portfolio of products and services, making it a leader in the eye care industry. Founded in 1945 in Switzerland, ALC has been a pioneer in developing innovative products and technologies for vision care, ranging from contact lenses to surgical equipment. In 2019, ALC became an independent company, separate from its parent company Novartis, with a mission to enhance quality of life by helping people see better. ALC's commitment to sustainability and social responsibility is evident in its efforts to reduce its carbon footprint and its partnerships with various organizations to provide eye care services to underserved communities. With a strong focus on research and development, ALC continues to introduce ground-breaking products and expand its global reach, solidifying its position as a leading player in the eye care industry. The company's dedication to excellence, coupled with its innovative approach, makes ALC a trusted and highly respected name in healthcare.